E-grāmata: Computational Modeling of Drugs Against Alzheimer's Disease

Recent Progress in the Treatment Strategies of Alzheimers
Disease.- Understanding the Mechanisms of Amyloid Beta (A) Aggregation by
Computational Modeling.- Recent Advances in Computational Modeling of BACE1
Inhibitors as Anti-Alzheimer Agents.- Modeling of BACE-1 Inhibitors as
Anti-Alzheimers Agents.- Computational Modeling of Kinase Inhibitors as
Anti-Alzheimer Agents.- Computer-Assisted Drug Design: A Toolbox for Novel
Tau Kinase Inhibitors and Its Implications in Alzheimers
Disease.- Computational Modeling Approaches in Search of Anti-Alzheimer
Agents: Case Studies of Phosphodiesterase Inhibitors.- Recent Advances in
Computational Modeling of Multi-Targeting Inhibitors as Anti-Alzheimer
Agents.- Computational Modeling of PET and SPECT Imaging Agents as
Diagnostics for Alzheimers Disease.- Computational Modeling of DYRK1A
Inhibitors as Potential Anti-Alzheimer Agents.- Computational Modeling of MAO
Inhibitors as Anti-Alzheimer Agents.- Computational Modeling of
Phosphodiesterase Inhibitors as Anti-Alzheimer Agents.- Computational Methods
for the Design and Development of Glutaminyl Cyclase Inhibitors in
Alzheimers Disease.- Basic Information Science Methods for Insight into
Neurodegenerative Pathogenesis.- Network Pharmacology for Drug Repositioning
in Anti-Alzheimer's Drug Development.- Web Services for the Prediction of
ADMET Parameters Relevant to the Design of Neuroprotective Drugs.